Clinical Trials List
Protocol NumberWN42636
Completed
2021-04-01 - 2026-03-31
Phase III
Recruiting2
-
Trial Applicant
Chugai Pharma Taiwan Ltd.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 蕭丞宗 Division of Neurology
- 賴冠霖 Division of Neurology
- Kon-Ping Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6(競爭型收案) participants
-
Global
185 participants
